Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The...
ADRO just broke a Resistance level @4.3, coincidentally, we also broke the SMA(200).
If ADRO can maintain its price above the SMA(200), consider the downtrend broken.
High RSI @69, OBV confirming.
CCI reaching 100, on uptrend.
*Be careful and ALWAYS use stop-limits as well as price-targets
Hello Successful Traders,
The stock (ADRO) has none-the-less endured a robust short (bearish) interval over the last few years. Considering the absence of a prevalent correction, there may be an opportunity formulating within the upcoming weeks (or months). Await confirmation prior to entering the market, as there can be numerous false (synthetic) market...